Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

hC Bioscience
125 Cambridgepark Dr.
Cambridge, MA 02140
Phone: 617-515-6755
https://hcbioscience.com/

hC Bioscience is dedicated to improving the lives of patients with the development of first-in-class tRNA-based therapeutics targeting protein dysfunction. hC Bioscience's innovative approach to precision protein editing has the potential to treat genetically defined conditions which account for 10-15% of all human disease. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). A single tRNA therapy has the potential to treat many diseases, regardless of the gene or location of the mutation.

Key Contact
Name
Leslie J. Williams
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
11/07/22 $40,000,000 Series A Extension 8VC
ARCH Venture Partners
Panacea Ventures
Taiho Ventures
Takeda Ventures
undisclosed


Featured Reading